Skip to main content
COSM logo
COSM
(NASDAQ)
Cosmos Health Inc.
$0.20-- (--)
Loading... - Market loading

Cosmos Health (COSM) Company Profile

Complete business overview, executive team, trading details, and corporate information.

Cosmos Health Inc.
COSMNasdaq Stock MarketHealthcareMedical Distribution

About Cosmos Health

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus. The company provides prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It offers ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names; and other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag; Otikon ear drops, which is a Class II medical device in the form of ear drops; and baby foods, such as organic powder milk, pasta with minced meat, whole grain rice cereals, whole grain cereal porridges, and organic rice creams with vanilla milk, as well as pear, carrot and banana purée under the Bio-bebe brand. It serves wholesalers and retail healthcare providers. The company was founded in 2009 and is headquartered in Thessaloniki, Greece.

Company Information

CEOGrigorios Siokas
Founded2009
IPO DateDecember 13, 2013
Employees163
CountryGreece
Fiscal YearJanuary - December

Stock Details

ExchangeNasdaq Stock Market (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Phone312 536 3102
Address
5 Agiou Georgiou Str, Pilea Thessaloniki, 55438 Greece

Corporate Identifiers

CIK0001474167
CUSIP221413206
ISINUS2214133058
EIN27-0611758
SIC5122

Leadership Team & Key Executives

Grigorios Siokas
Chairman and Chief Executive Officer
Georgios Terzis
Chief Financial Officer
Nikolaos Bardakis
Chief Operating Officer
Demetrios G. Demetriades
Secretary and Independent Director
Prof. Dimitrios Trafalis
Head of Oncology